Forecasting Myopic Maculopathy Risk Over a Decade: Development and Validation of an Interpretable Machine Learning Algorithm
Investigative Ophthalmology & Visual Science · 2024
DOI: 10.1167/iovs.65.6.40 ↗At a glance
Validierungsstudie in Investigative Ophthalmology & Visual Science, 2024. Written by Yanping Chen and 8 co-authors. Institution: State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-Sen University, Guangdong Provincial Key Laboratory of Ophthalmology and …. Major MEDLINE topics: Machine Learning, Tomography, Optical Coherence, Disease Progression, Algorithms. Cited 19 times so far (Crossref); 44 references. The full text is freely available (open access, CC BY-NC-ND 4.0).
Abstract (original language)
Purpose
The purpose of this study was to develop and validate prediction model for myopic macular degeneration (MMD) progression in patients with high myopia.
Methods
The Zhongshan High Myopia Cohort for model development included 660 patients aged 7 to 70 years with a bilateral sphere of ≤-6.00 diopters (D). Two hundred twelve participants with an axial length (AL) ≥25.5 mm from the Chinese Ocular Imaging Project were used for external validation. Thirty-four clinical variables, including demographics, lifestyle, myopia history, and swept source optical coherence tomography data, were analyzed. Sequential forward selection was used for predictor selection, and binary classification models were created using five machine learning algorithms to forecast the risk of MMD progression over 10 years.
Results
Over a median follow-up of 10.9 years, 133 patients (20.2%) showed MMD progression in the development cohort. Among them, 69 (51.9%) developed newly-onset MMD, 11 (8.3%) developed patchy atrophy from diffuse atrophy, 54 (40.6%) showed an enlargement of lesions, and 9 (6.8%) developed plus signs. Top six predictors for MMD progression included thinner subfoveal choroidal thickness, longer AL, worse best-corrected visual acuity, older age, female gender, and shallower anterior chamber depth. The eXtreme Gradient Boosting algorithm yielded the best discriminative performance (area under the receiver operating characteristic curve [AUROC] = 0.87 ± 0.02) with good calibration in the training cohort. In a less myopic external validation group (median -5.38 D), 48 patients (22.6%) developed MMD progression over 4 years, with the model's AUROC validated at 0.80 ± 0.008.
Conclusions
Machine learning model effectively predicts MMD progression a decade ahead using clinical and imaging indicators. This tool shows promise for identifying "at-risk" high myopes for timely intervention and vision protection.
Subjects
MeSH terms (MEDLINE)
Authors and institutions
- State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-Sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangdong Provincial Clinical Research Center for Ocul…
- School of Optometry, The Hong Kong Polytechnic University, Kowloon, Hong Kong, China.
- Research Centre for SHARP Vision (RCSV), The Hong Kong Polytechnic University, Kowloon, Hong Kong, China.
- Center for Eye Research Australia, Royal Victorian Eye and Ear Hospital, Melbourne, VIC, Australia.
- Hainan Eye Hospital and Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-Sen University, Haikou, Hainan Province, China.
- https://orcid.org/0000-0002-5273-3332.
Cite
APA
Chen, Y., Yang, S., Liu, R., Xiong, R., Wang, Y., Li, C., Zheng, Y., He, M., & Wang, W. (2024). Forecasting Myopic Maculopathy Risk Over a Decade: Development and Validation of an Interpretable Machine Learning Algorithm. Investigative Ophthalmology & Visual Science. https://doi.org/10.1167/iovs.65.6.40
Vancouver
Chen Y, Yang S, Liu R, Xiong R, Wang Y, Li C, et al. Forecasting Myopic Maculopathy Risk Over a Decade: Development and Validation of an Interpretable Machine Learning Algorithm. Investigative Ophthalmology & Visual Science. 2024. doi:10.1167/iovs.65.6.40
BibTeX
@article{Chen2024,
author = {Chen, Yanping and Yang, Shaopeng and Liu, Riqian and Xiong, Ruilin and Wang, Yueye and Li, Cong and Zheng, Yingfeng and He, Mingguang and Wang, Wei},
title = {Forecasting Myopic Maculopathy Risk Over a Decade: Development and Validation of an Interpretable Machine Learning Algorithm},
journal = {Investigative Ophthalmology & Visual Science},
year = {2024},
doi = {10.1167/iovs.65.6.40}
}
EUVIMED